Financials
- Market Capitalization 209.2 M
- Employee 87
- Founded 2015
- CEO N/A
- Website www.kerostx.com
- Headquarter Massachusetts, United States
- FIGI BBG00H1HP9G9
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-4.36
Fiyat/satışlar oranı
13.69
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3592 | AGEN Agenus Inc. - Common Stock | 5.08 USD | -16.99% | +47.25% | +55.83% | -19.11% | 211.54 M USD | ||
| 3595 | SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 75.39 USD | +2.00% | -4.57% | +3.26% | +843.55% | 210.05 M USD | ||
| 3601 | OTLK Outlook Therapeutics, Inc. - Common Stock | 1.73 USD | +11.61% | +21.83% | +45.38% | +319.39% | 209.09 M USD | ||
| 3602 | RNA Atrium Therapeutics, Inc. - Common Stock | 12.22 USD | 0.00% | -6.50% | -4.16% | -82.62% | 209.03 M USD |